Nexavar
Term · Oncology and biomedicine · MLC-T-ONC-005802
A drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. Nexavar blocks certain proteins, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Nexavar is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called BAY 43-9006 and sorafenib tosylate.
| Identifier | MLC-T-ONC-005802 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | BAY 43-9006; sorafenib tosylate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005802",
"term": "Nexavar",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. Nexavar blocks certain proteins, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Nexavar is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called BAY 43-9006 and sorafenib tosylate.",
"synonyms": [
"BAY 43-9006",
"sorafenib tosylate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/nexavar/"
}
Record 11,789 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.